Clinical and prognostic significance of pathological reclassification in ovarian neuroendocrine tumors: a retrospective study (O-NET study)

Clinical and prognostic significance of pathological reclassification in ovarian neuroendocrine tumors: a retrospective study (O-NET study) - Clinical and prognostic significance of pathological reclassification in ovarian neuroendocrine tumors: a retrospective study (O-NET study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019754

Enrollment

Registered

2015-11-11

Start date

2015-11-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary ovarian neuroendocrine tumors

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with pathologically diagnosis of primary ovarian neuroendocrine tumor for the periods from 1995 to 2014.

Exclusion criteria

Exclusion criteria: Multiple malignancies within five years.

Design outcomes

Primary

Measure	Time frame
Overall survival time	—

Secondary

Measure	Time frame
Progression free survival time	—

Countries

Japan

Contacts

Public ContactKentaro Kai

Oita University Faculty of Medicine Department of Obstetrics and Gynecology

kenta9sp@oita-u.ac.jp097-586-5922

Outcome results